Location: | London |
---|---|
Salary: | £43,305 to £50,685 per annum (pro-rata), inclusive of London Allowance |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 30th January 2025 |
---|---|
Closes: | 13th February 2025 |
Job Ref: | 4790 |
About the Role
The Cancer Imaging Laboratory in the Centre for Cancer Biomarkers and Biotherapeutics at Barts Cancer Institute seeks to recruit an experienced radiochemist PDRA to carry out research in the field of radionuclide imaging and therapy of paediatric cancer. The role also covers the radiopharmaceutical development work required to support a key industrial partner as well as academic group members and collaborators.
About You
Applicants must have a PhD in radiochemistry or radiopharmaceutical science, covering a wide variety of radionuclides, in particular radiometals for imaging and therapy. You will be ready to develop your career, wanting to apply your radiochemistry knowledge to the challenge of developing radiolabeling strategies for a constantly changing range of precursors and targeting vectors in an industrial context. You will be keen to maintain and develop your laboratory practical skills and your research in preclinical radiation science.
About the School/Department/Institute/Project
The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
In return, we offer 30 days’ leave per annum, access to a pension scheme, a season ticket loan scheme and competitive salaries. We also offer enhanced family friendly leave, and an on-site nursery at the Mile End campus. You will also work with a friendly team, with personal development opportunities.
The post is based at the Charterhouse Square Campus in London. It is full time (35 hours per week), fixed term appointment for 2 years, with an expected start date of March 2025. The starting salary will be Grade 5, in the range of £43,305 - £50,685 per annum (pro-rata), inclusive of London Allowance.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability.
Closing Date: 13/02/2025, 23:55
Type / Role:
Subject Area(s):
Location(s):